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Abstract 21 
Background: This systematic review aimed to summarise epidemiological evidence regarding 22 
long-term effects of prenatal and infant fine particulate matter (PM2.5) exposure on wheezing and 23 
asthma. 24 
Methods: Epidemiological data investigating the associations between ambient PM2.5 exposures 25 
during prenatal or the first two years of life and wheezing or asthma throughout life was extracted 26 
from five databases. All included studies were assessed according to the Critical Appraisal Skills 27 
Programme checklists. We performed meta-analyses if ≥2 studies estimated the effects of 28 
continuous PM2.5. 29 
Results: Nine of 18 eligible studies were suitable for meta-analyses. For prenatalPM2.5 exposure 30 
and asthma by age 10 (n=4), the overall risk estimate (per 10-unit increase (95% confidence 31 
interval) was 1.12 (1.00-1.26). While meta-analysis of prenatal exposure and wheezing by age 4 32 
(n=5) was not possible due to inconsistent exposure and outcome assessments, four studies found 33 
strong positive associations with wheeze by age 2. The overall risk of developing asthma (n=5) 34 
and wheezing (n=3) by age 8 for infant PM2.5 exposure was 1.14 (0.96-1.35) and 1.49 (0.99-2.26), 35 
respectively. One large high-quality study reporting risk differences not suitable for meta-36 
analysis demonstrated significant associations between prenatal or infant PM2.5 exposure and 37 
childhood asthma. High heterogeneity was present among studies of prenatal exposures and 38 
asthma, while studies of other associations showed low heterogeneity. There was insufficient 39 
evidence about susceptible sub-groups. 40 
Conclusions: The limited and inconsistent evidence is suggestive of an association between early 41 
life PM2.5 exposure and wheezing/asthma. Large standardised studies are needed to explore the 42 
associations and identify vulnerable populations.  43 
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 45 
What this study adds: this systematic review provided synthesised results on long-term impacts 46 
of prenatal and infant fine particulate matter exposure and development of wheezing or asthma 47 
based on the existing evidence. It also highlighted limitations to current research in this rapidly 48 
developing field and recommended future epidemiological studies to use standardised designs 49 
and evaluate susceptible populations to assist policy makers in improving public health. 50 
 51 
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1. Introduction 67 
Exposure to fine particulate matter (PM2.5) is a well-recognised global public health issue. It has 68 
been estimated that mortality from PM2.5 exposure increased from approximately 3.5 million in 69 
1990 to 4.2 million in 2015.[1] Globally, the association between PM2.5 exposure, wheezing and 70 
asthma has been widely studied.[2-4] Short-term (e.g. daily) increases in PM2.5 have a well-71 
established association with worsening asthma symptoms and increases in hospital attendance 72 
rates,[5] while long-term exposure has been shown to increase the risk of developing asthma.[6] 73 
However, few studies have evaluated the long-term impacts of exposure during early life.   74 
 75 
The period from in utero to the first 2 years of life is a critical window for lung development and 76 
growth.[7-8] Increasingly, studies have suggested that exposure to air pollution during this period 77 
could increase the risk of developing wheezing and/or asthma in later life. For example, a 78 
systematic review has found a significant association between prenatal exposure to particulate 79 
matter with an aerodynamic diameter less than 10 µm (PM10) and childhood asthma
[9] with in 80 
vivo laboratory models suggesting that this relationship is causal.[10-11] 81 
 82 
However, the identified associations in the literature between PM2.5 exposure during this critical 83 
period and the long-term risk of wheezing and asthma are inconsistent. For example, an 84 
American study suggested that childhood asthma was significantly associated with prenatal 85 
PM2.5 exposure as estimated by a land use regression (LUR) model (odds ratio (OR): 1.17; 95%CI 86 
(confidence interval): 1.04-1.30),[12] while a Canadian study using a similar methodological 87 
approach did not observe associations.[13] These inconsistencies might be explained by 88 
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differences in PM2.5 sources, exposure and outcome measurements, and analytic approaches in 89 
different studies, making further analysis necessary to better assess this relationship.  90 
 91 
Previous systematic reviews have focused on the effects of either prenatal exposure alone [9] or 92 
many years of exposure to traffic-related air pollution.[3, 6] The aim of this systematic review was 93 
to identity and summarise the available epidemiological evidence for the association between 94 
prenatal or infant (less than 2 years of age) exposure to PM2.5 and the subsequent development 95 
of wheezing and asthma. 96 
 97 
 98 
2. Methods 99 
We followed the Cochrane guidelines[14] and the Preferred Reporting Items for Systematic 100 
Reviews and Meta-Analyses (PRISMA) checklist[15] [See PRISMA 2009 Checklist, 101 
Supplemental Digital Content, which provides details of the checklist]. 102 
2.1. Search strategy 103 
We initially searched PubMed, Scopus, Web of Science core collection, ProQuest and Cochrane 104 
library on 11/05/2016 for scientific articles. We used a combination of free text words found in 105 
the title, abstract and key words (Table 1). 106 
We included all respiratory outcomes in the search terms in order to reduce the loss of 107 
potentially relevant papers. There was no restriction on publication date. Articles that were not 108 
written in English were excluded. We updated the database search and searched the reference 109 
lists of all included studies by 4/12/2017.  110 
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2.2. Study screening 111 
We screened titles and abstracts of all included papers for potential relevance. After that, full 112 
texts of all relevant studies were reviewed based on the following inclusion and exclusion criteria. 113 
We included all epidemiological studies which: 114 
1. Were peer-reviewed journal articles, conference proceedings, theses and official reports 115 
using a cohort, case-control or cross-sectional design; 116 
2. Evaluated the effects of exposure to PM2.5 prenatally or during the first 2 years of life; 117 
3. Assessed the impact of prenatal and infant PM2.5 exposure on wheezing and asthma incidence 118 
or prevalence ≥1 year after the exposure period investigated. 119 
 120 
Studies were excluded if they: 121 
1. Were experimental studies, reviews, meeting abstracts, book sections, blogs, newspaper 122 
articles, editorials or non-research letters; 123 
2. Only assessed maternal PM2.5 exposure before conception or childhood exposure after 2 years 124 
of age; 125 
3. Only assessed indoor air pollution, tobacco smoke, or other air pollution exposure metrics;  126 
4. Only assessed other respiratory illnesses or symptoms. 127 
5. Assessed acute effects of PM2.5 exposure. 128 
2.3. Data extraction 129 
Data was extracted manually from all eligible studies for information on study design, location, 130 
population characteristics, exposure, outcomes, confounding factors and effect estimates with 131 
95%CIs. We contacted the corresponding authors of studies with important data missing.  132 
2.4. Critical appraisal 133 
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We examined the quality of all included studies using the Critical Appraisal Skills Programme 134 
(CASP) checklists[16-17] [See CASP checklist for cohort study and CASP checklist for case-135 
control study, Supplemental Digital Content, which provides details of these checklists].  136 
2.5. Analysis 137 
We employed random-effects meta-analyses to calculate the weighted effect estimates and 138 
95%CIs for every 10 µg·m-3 increase in PM2.5 concentrations. Meta-analysis was conducted if 139 
≥2 studies reporting ORs, RRs or HRs using continuous PM2.5 concentrations as an independent 140 
variable. Studies reporting ORs, RRs or HRs were combined in a single meta-analysis as this is 141 
acceptable for common outcomes with a small effect size[18] and is a well-established approach.[6, 142 
19] All meta-analyses were performed on Review Manager 5.3 (Copenhagen: The Nordic 143 
Cochrane Centre, The Cochrane Collaboration, 2014) using the generic inverse variance method. 144 
Heterogeneity was assessed using the I2 statistic and p value from the Chi-squared test. 145 
Publication bias was visually evaluated using funnel plots. We conducted sensitivity analyses by 146 
employing fixed-effects models, excluding case-control studies, and excluding studies estimating 147 
exposure using techniques other than the most common approach of LUR. Since one study[20] 148 
used both LUR and inverse distance weighted (IDW) approaches to estimate PM2.5 exposure, we 149 
included LUR in the primary meta-analysis and used IDW in the sensitivity analysis. 150 
 151 
 152 
3. Results 153 
3.1. Study screening 154 
Our search strategy initially identified 8031 articles (Figure 1). After removing duplicates 155 
(n=3326) and conducting the first screening of titles and abstracts (n=4705), we reviewed 111 156 
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full texts articles which yielded 13 relevant studies. We added five more articles by further 157 
searching for new publications and reference lists of all the included articles. Eighteen studies 158 
were included in our final review consisting of 17 peer-reviewed journal articles and 1 Thesis 159 
[See eTable 1, Supplemental Digital Content, which provides details].  160 
3.2. Study setting 161 
All 18 studies were published between October 2002 and January 2018. The majority of the 162 
studies were conducted in North American and European countries, including 5 in America,[12, 163 
21-24] 3 in Canada,[13, 20, 25] 3 in Poland,[26-28] 2 in Germany,[29-30] 1 in The Netherlands[31] and 1 in 164 
the Czech Republic.[32] One study was conducted in Mexico.[33] The remaining two studies were 165 
pooled analyses of multi-centre cohorts conducted in Canada, Germany and The Netherlands.[34-166 
35] Sample sizes ranged from 184 to 41,569 and follow-up periods ranged from 2 to 10 years. 167 
Most of the studies (n=16) focused on the general population (2 to 21 years of age), except one 168 
study of high-risk children (i.e. ≥1 first-degree asthmatic relative or ≥2 first-degree relatives with 169 
other IgE-mediated allergic disease)[25] and another on ethnic minorities.[23] 170 
3.3. Study design 171 
Most of the studies were pregnancy or birth cohort studies (n=15) including two pooled analyses 172 
of multiple birth cohorts from different locations.[34-35] The remaining three[13, 20, 23] were matched 173 
case-control studies in which two were nested within birth cohorts.[13, 20] 174 
3.4. PM2.5 sources and measurements 175 
There were 11 studies evaluating outdoor PM2.5 from traffic-related sources,
[12-13, 20, 22, 24-25, 29-31, 176 
34-35] woodsmoke,[20] industrial points[20] or other sources,[12, 22] while three investigated PM2.5 177 
from both outdoor and indoor sources.[26-28] The remaining four studies did not specify the source 178 
of ambient PM2.5.
[21, 23, 32-33] 179 
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Various methods were used for estimating prenatal and infant PM2.5 exposure. The LUR model 180 
was mostly based on Geographic information systems (GIS) [13, 20, 25, 29-31, 34-35] or satellite data.[12, 181 
21-22, 33] Studies estimating prenatal PM2.5 exposure
[12-13, 20-22, 33] have taken into account 182 
participants’ residential histories, while studies estimating postnatal exposure[25, 29-31, 34-35] only 183 
used birth address. Other studies employed an IDW approach[20, 23] or a dispersion model[24] based 184 
on individual’s residential histories, personal environmental monitoring samplers (PEMS)[26-28] 185 
and data from the central monitoring sites.[32] 186 
3.5. Outcome definition 187 
The majority of the included studies (n=13) relied on questionnaires or interviews to define 188 
doctor-diagnosed wheezing and asthma (Table 1). There were four studies defining asthma from 189 
medical records as different combinations of physician diagnoses, hospital admissions and 190 
asthma-related medication use.[13, 20, 24, 32] One study diagnosed asthma by a blinded paediatric 191 
allergist based on the presence of asthmatic symptoms.[25] We included parental reports of doctor 192 
diagnosed asthmatic/spastic/obstructive bronchitis as an indication of asthma in two German 193 
studies[29-30] due to the relatively low asthma frequency and the strict diagnostic criteria for pre-194 
school asthma.[34] 195 
3.6. Quality assessment 196 
According to the CASP checklists, all the studies were highly [13, 20-22, 24, 32] or moderately 197 
qualified[12, 23, 25-31, 33-35] [See eTable 2-3, Supplemental Digital Content, which provides details]. 198 
The major concerns for the validity of the studies were potential for information bias (n=13), 199 
selection bias (n=10), short follow-up duration (n=9) and not accounting for important 200 
confounding factors (n=8) [See eTable 2, eTable 3 and Notes for CASP quality assessment of all 201 
included studies, Supplemental Digital Content, which provides details].  202 
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3.7. PM2.5 exposure and wheezing/asthma  203 
3.7.1 Prenatal PM2.5 exposure and asthma 204 
Of the six studies assessing prenatal PM2.5 exposure and asthma development, four were included 205 
in the meta-analysis,[12-13, 20, 32] while the other two either contained overlapping data[22] or 206 
investigated the RDs,[24] respectively. The overall risk of developing childhood asthma for a 10 207 
µg·m-3 increase in prenatal PM2.5 exposure was 1.12 (95%CI: 1.00-1.26), with borderline 208 
significance (p=0.050) (Figure 2). We found high heterogeneity among those studies (I2=73%; 209 
p=0.0005). Sensitivity analyses all found similar but non-significant associations between 210 
prenatal PM2.5 exposure and asthma development(Table 2; see eFigure 1, Supplemental Digital 211 
Content, which provides details). 212 
The meta-analyses did not include a recent study using RDs to estimate the effect of prenatal 213 
PM2.5 exposure on asthma development of nearly 20,000 American children.
[24] In this study, the 214 
authors found significant positive associations between log-transformed prenatal PM2.5 exposure 215 
(per 2.7-fold increase) and cumulative asthma incidences from age 2 to age 6 with RDs ranging 216 
from 0.015 to 0.035 after adjustment for confounders. Sensitivity analysis of modelling exposure 217 
by quintiles also revealed significant associations between prenatal PM2.5 exposure and asthma 218 
incidence and persistence by age 5. However, modelling PM2.5 linearly resulted in positive 219 
associations but with no statistical significance [See eTable 4, Supplemental Digital Content, 220 
which provides details]. 221 
3.7.2 Infant PM2.5 exposure and asthma 222 
There were nine studies evaluating the associations between infant PM2.5 exposure and asthma. 223 
These included one for birth year exposure,[25] four for exposure during the first of life[20, 23-24, 35] 224 
and four for exposure during first 2 years of life.[29-31, 34] After excluding four studies either with 225 
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repeated data[25, 29, 31] or estimating the effect by RDs,[24] five remained in the meta-analyses.[20, 226 
23, 30, 34-35] Our meta-analyses showed a trend towards a positive association that was not 227 
statistically significant (overall OR: 1.14; 95%CI: 0.96-1.35) with low heterogeneity (I2=0%; 228 
p=0.480) (Figure 3). The results were robust to multiple sensitivity analyses (Table 2; see eFigure 229 
2-3, Supplemental Digital content, which provides details).  230 
One study also analysed the outcomes as current asthma or ever asthma plus current wheeze in 231 
their regression models,[35] which was not included in the meta-analyses. According to the results 232 
of those analyses, infant PM2.5 exposure was found to be significantly associated with an 233 
increased risk of current asthma of 35% (95%CI: 7%-70%) at age 6 to 8, while ever asthma plus 234 
current wheeze did not show statistically significant associations [See eTable 4, Supplemental 235 
Digital Content, which provides details]. 236 
In the study assessing RDs,[24] significant associations were observed for PM2.5 exposure during 237 
the first year of life and incident or persistent asthma when modelling exposure as a log-238 
transformed continuous variable and by quintiles. Similar with the results of prenatal PM2.5 239 
exposure, modelling the PM2.5 as a continuous variable without log-transformation revealed non-240 
significant associations. However, goodness-of-fit analyses suggested that the log-transformed 241 
modelling was better than the linear continuous modelling. Other sensitivity analyses all 242 
suggested significant associations [See eTable 4, Supplemental Digital Content, which provides 243 
details]. 244 
3.7.3 Prenatal PM2.5 exposure and wheezing 245 
Meta-analysis was not applicable for the five studies of prenatal PM2.5 exposure and wheezing 246 
since most of the studies categorised PM2.5 exposure by median and had different outcome 247 
definitions.[21, 26-28] 248 
 11 
 
There was only one study that modelled PM2.5 as a continuous variable using regression 249 
analyses.[33] The authors evaluated the effect of PM2.5 exposure during different trimesters of 250 
pregnancy on ever or current wheeze (wheeze in the past year) in 552 4-year-old children. No 251 
significant association was observed in any trimester PM2.5 exposure and wheezing outcomes.  252 
Another study suggested that higher prenatal PM2.5 exposure (>11.22 µg·m
-3) was significantly 253 
associated with a 102% increase (95%CI: 20%-240%) in the risk of repeated wheezing in 254 
children from birth to 2 years old compared with the lower exposure group (≤11.22 µg·m-3), with 255 
consistent results from multiple sensitivity analyses.[21]  256 
The other three studies were from the same project – the Krakow study[26-28] which used PEMS 257 
to measure PM2.5 exposure during the 2
nd trimester of pregnancy. All studies suggested 258 
significant associations between prenatal PM2.5 exposure and wheezing duration in the first 2 259 
years of life; however, while the association for ages 3 to 4 was also positive, it was not 260 
statistically significant [See eTable 4, Supplemental Digital Content, which provides details]. 261 
3.7.4 Infant PM2.5 exposure and wheezing 262 
Meta-analyses included three of the four studies investigating the association between infant 263 
PM2.5 and wheezing,
[30-31, 35] while the other one containing repeated data was excluded.[29] Infant 264 
PM2.5 exposure was not associated with wheezing development in either random- or fixed-effects 265 
models (overall OR: 1.49; 95%CI: 0.99-2.26) (Figure 4; see eFigure 4, Supplemental Digital 266 
Content, which provides details). Low heterogeneity was found in the three studies as indicated 267 
by an I2=0% and a p value=0.770. PM2.5 was also not significantly associated with current wheeze 268 
at age 6 to 8[35] [See eTable 4, Supplemental Digital Content, which provides details]. 269 
3.8. Publication bias 270 
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 Small studies with negative findings have not been published on the associations between 271 
prenatal or infant PM2.5 exposure and asthma. The distribution was symmetrical in the funnel plot 272 
of infant exposure and wheezing, despite the small number of studies included in the meta-273 
analysis [See eFigure 5-7, Supplemental Digital Content, which provides details]. 274 
3.9. Outcomes by specific characteristics 275 
There were nine studies including stratified analyses by gender,[12-13, 20, 22-24, 29] heredity,[23-24] 276 
maternal stress during pregnancy,[12, 33] race,[24] atopic status[23] and other characteristics 277 
including birthweight, gestational length, maternal age, parity, neighbourhood SES[13] and 278 
genotype[35] [See eTable 4, Supplemental Digital Content, which provides details]. 279 
The differences of effects by gender were inconsistent among the seven studies. To illustrate, 280 
two studies suggested larger magnitudes of effects in males compared with females,[12, 22] while 281 
the other five suggested stronger effects in females.[13, 20, 23-24, 29] Of those studies, Hsu and 282 
colleagues[22] reported significant associations in males exposed to PM2.5 during the 12-26
th 283 
gestational weeks with asthma development, while Pennington and colleagues[24] reported 284 
significant associations between infant PM2.5 exposure and asthma development in females. 285 
Other studies did not show significant results among different genders. 286 
Higher risk was shown for children with a family history of asthma than those without in one 287 
study,[23] while the other one[24] only found significantly increased risks of asthma in children of 288 
mothers without asthma, but not in children of mothers with asthma.  289 
Stratified analyses by maternal stress during pregnancy revealed a consistently significant and 290 
increased risk in children whose mothers were highly stressed during pregnancy compared with 291 
those slightly stressed.[12, 33] 292 
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Only one study[24] tested for potential effect modification by race or ethnicity and found no 293 
statistical differences between groups described as ‘white’ or ‘black’.  294 
 Studies that evaluated atopic status[23] and other characteristics including birthweight, maternal 295 
age, parity, gestational length and SES[13] did not find any significant associations with asthma. 296 
However, evidence of effect modification was seen with birthweight. Children with a birthweight 297 
<2500 g were at a higher risk of developing asthma associated with prenatal PM2.5 exposure. 298 
Children with the GSTP1, rs1138272 or rs1695 minor alleles were more susceptible to 299 
developing asthma associated with infant PM2.5 exposure.
[35] 300 
 301 
 302 
4. Discussion 303 
Our meta-analyses demonstrated positive associations between prenatal PM2.5 exposure and 304 
asthma and infant PM2.5 exposure, and both wheezing and asthma however there were a limited 305 
number of relevant studies and the results were inconsistent. There was high heterogeneity 306 
among the studies for prenatal PM2.5 exposure and asthma. This might be due to the variability 307 
in children’s ages, exposure measurement methods, sources of particulate matter, outcome 308 
definitions, and adjustment of confounding factors. Studies investigating prenatal PM2.5 exposure 309 
and subsequent wheezing were not amenable to meta-analysis but consistently reported 310 
significant associations, especially in infants (≤2 years).  311 
This is the largest review assessing long-term effects of prenatal and infant PM2.5 exposure on 312 
subsequent wheezing or asthma. We added three more studies[12, 32-33] to a previous systematic 313 
review and meta-analysis of the effects of prenatal exposure to all types of air pollutants including 314 
PM2.5 on the development of wheezing and asthma.
[9] Our results of meta-analyses of the 315 
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association between prenatal PM2.5 exposure and asthma were similar to this previous review, 316 
observing no significant associations and high heterogeneity. In contrast, the other new study not 317 
included in meta-analysis reported significantly increased risk of asthma by age 2 to 6 after 318 
prenatal exposure to PM2.5.
[24] However, the evidence was mixed, with more significant 319 
associations seen in children followed to school age[12, 24, 32] than preschool age.[20, 24] This 320 
phenomenon might be explained by the difficulties in the diagnosis of asthma among young 321 
children,[36] leading to the underestimation of physician diagnosed asthma in this population. The 322 
significant associations between prenatal PM2.5 exposure and wheezing in infants
[26-28] rather than 323 
in older children[28, 33] could indirectly support this explanation. However, some researchers 324 
argue that it is difficult to predict asthma based solely on early life wheezing as less than half of 325 
children with episodes of preschool wheezing will have continuing childhood asthma.[37] 326 
For infant PM2.5 exposure and the subsequent development of wheezing or asthma, our meta-327 
analyses did not demonstrate an association. However, these studies were of higher risk of bias 328 
due to potential for selection bias,[23, 30-31, 34-35] recall bias,[23, 30-31, 34-35] not adjusted for important 329 
confounding factors,[20, 35] and a case-control design.[20, 23] In contrast, a recent large, high quality 330 
cohort study of nearly 20,000 children revealed positive associations between PM2.5 exposure 331 
during the first year of life and asthma incidence by age 6, despite not adjusting for important 332 
confounders.[24] This result was robust to different asthma definitions but sensitive to PM2.5 333 
modelling decisions and covariate controls. Overall, the small number of studies identified in this 334 
systematic review limited our confidence in conclusively suggesting the presence or absence of 335 
associations. Studies with a larger sample size, a standardised exposure estimate method, more 336 
accurate outcome assessment approaches and greater statistical power are needed to further 337 
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explore the long-term effects of prenatal and infant PM2.5 exposure on asthma or wheeze 338 
development. 339 
Our review also highlights the limited evidence of susceptible populations to prenatal and infant 340 
PM2.5 exposure. Children whose mothers were exposed to negative life events during pregnancy 341 
were more likely to develop wheezing or asthma after prenatal and infant PM2.5 exposure than 342 
those not exposed. The different effects of PM2.5 exposure by gender and heredity were 343 
inconsistent between studies. There was insufficient evidence to suggest that race, low birth 344 
weight and specific genotypes could increase the risk of wheezing or asthma development after 345 
PM2.5 exposure, while the effects of atopic status, gestational length, maternal age, parity and 346 
SES require further investigation. 347 
The main strength of our systematic review was the comprehensive search strategy and 348 
reproducible evaluation of current evidence. Our findings provide a timely contribution to the 349 
rapidly developing field, which could highlight limitations and guide future studies. However, 350 
some limitations should also be acknowledged. Firstly, evidence of prenatal and infant PM2.5 351 
exposure and wheezing or asthma is still limited. In addition, publication bias might be present 352 
in studies evaluating early life PM2.5 exposure and asthma. Therefore, any conclusions should be 353 
made with caution and confirmed by further investigations. Secondly, high variability was found 354 
between studies in study design, exposure estimating methods, outcome assessment approaches, 355 
participants’ ages at assessment and adjustment of confounders, especially in those evaluating 356 
prenatal PM2.5 exposure and asthma. Future syntheses of evidence in this area will benefit from 357 
more studies using standardised designs and methods. In addition, diagnosis of asthma in young 358 
children is difficult and outcome misclassification is inevitable in this population. Finally, the 359 
major source of PM2.5 in this systematic review was traffic, with scarce evidence regarding the 360 
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long-term respiratory effects of early life PM2.5 exposure from other sources such as wildfire 361 
smoke, which is an increasing global concern due to climate change.[38-39] More research on PM2.5 362 
from other sources is needed to guide public health responses. 363 
 364 
 365 
5. Conclusions 366 
Prenatal and infant PM2.5 exposure was not clearly associated with subsequent development of 367 
wheezing or asthma in our review of the literature. The strongest evidence was for an association 368 
between prenatal PM2.5 exposure and wheezing in infants, while in-utero exposure and asthma 369 
had a borderline positive overall effect estimate. However, evidence was insufficient and mixed, 370 
indicated by a small number of studies included in the meta-analyses and inconsistent results. 371 
Further research is necessary to explore the associations using harmonised exposure methods and 372 
appropriate statistical analyses controlling for important covariates. Furthermore, studies of 373 
susceptible populations and other sources of PM2.5 are needed to help policy makers improving 374 
public health. 375 
 376 
 377 
 378 
 379 
 380 
 381 
 382 
 17 
 
Appendix 383 
Supplemental Digital Content: this supplementary material includes the PRISMA 2009 384 
checklist, information on CASP quality assessment, and figures/tables listed below. 385 
eFigure 1. Sensitivity analysis of the association between prenatal PM2.5 exposure (per 10 µg·m
-386 
3) and asthma 387 
eFigure 2. Fixed-effects meta-analysis of the association between infant PM2.5 exposure (per 10 388 
µg·m-3) and asthma 389 
eFigure 3. Sensitivity analysis of the association between infant PM2.5 exposure (per 10 µg·m
3) 390 
and asthma 391 
eFigure 4. Fixed-effects meta-analysis of the association between infant PM2.5 exposure (per 10 392 
µg·m-3) and wheezing 393 
eFigure 5. Funnel plot – fixed-effects meta-analysis of the association between prenatal PM2.5 394 
exposure and asthma 395 
eFigure 6. Funnel plot – fixed-effects meta-analysis of the association between infant PM2.5 396 
exposure and asthma 397 
eFigure 7. Funnel plot-fixed-effects meta-analysis of the association between infant PM2.5 398 
exposure and wheezing 399 
eTable 1. Summary of studies included in the systematic review 400 
eTable 2. Risk of bias assessment for cohort studies according to the CASP checklist 401 
eTable 3. Risk of bias assessment for case-control studies according to the CASP checklist 402 
eTable 4. Original risk estimates of the 18 studies investigating prenatal and infant PM2.5 403 
exposure and wheezing/asthma development 404 
 405 
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Table 1. Items for database search 406 
Population Connecting word Exposure Connecting word Outcome 
perinatal AND “air pollution” AND respirat* 
post-natal “air pollutant*” lung 
prenatal particle* pulmon* 
pre-natal “particulate matter*” bronchi* 
maternal  “air way” 
pregnan*  airway 
gestation  asthma 
conception  cough 
fetus*  wheeze 
foetus*  wheezing 
fetal   
newborn*   
“new born*”   
infant*   
Notes: Asterisk represents any combination of letters; double quotation marks represent that the two words should 407 
not be broken apart.  408 
 409 
 410 
 411 
 412 
 413 
 414 
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Table 2. Prenatal and infant PM2.5 exposure (per 10 µg·m
-3 increase) on wheezing/asthma from 415 
the sensitivity meta-analyses 416 
 Sensitivity analysis 1: 
fixed-effects OR (95%CI); I2 
(p* value) 
Sensitivity analysis 2: 
excluding case-control 
studies  
random-effects OR 
(95%CI); I2 (p* value) 
Sensitivity analysis 3: 
excluding studies with other 
exposure estimates 
approaches except LUR 
random-effects OR 
(95%CI); I2 (p* value) 
Prenatal PM2.5 & asthma N.A. 1.17 (0.99 to 1.37); 78% 
(0.001) 
1.16 (0.91 to 1.48); 77% 
(0.004) 
Infant PM2.5 & asthma 1.14 (0.96 to 1.35); 0% 
(0.480) 
1.27 (0.82 to 1.98); 22% 
(0.280) 
1.16 (0.92 to 1.44); 9% 
(0.360) 
Infant PM2.5 & wheezing 1.49 (0.99 to 2.26); 0% 
(0.770) 
N.A. N.A. 
Abbreviations: OR, odds ratio; 95%CI, 95% confidence interval; LUR, land use regression; PM2.5, particulate 417 
matter with an aerodynamic diameter less than 2.5 µm; N.A., not applicable. Significant associations are shown in 418 
bold. *, p-value refers to the test of heterogeneity. 419 
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 427 
Figure 1. PRISMA flow diagram describing the database search and study screening process  428 
 429 
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Figure 2. Random-effects meta-analysis of the association between prenatal PM2.5 exposure 440 
(per 10 µg·m-3) and asthma 441 
 442 
 443 
 444 
 445 
 446 
 447 
 448 
 449 
 450 
 451 
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 452 
Figure 3. Random-effects meta-analysis of the association between infant PM2.5 exposure (per 453 
10 µg·m-3) and asthma  454 
 455 
 456 
 457 
 458 
 459 
 460 
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 462 
 463 
 464 
 465 
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 467 
Figure 4. Random-effects meta-analysis of the association between infant PM2.5 exposure (per 468 
10 µg·m-3) and wheezing469 
 24 
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